COMPANY PRODUCT TYPE THERAPEUTIC AREA INDICATION PHASE STUDIES LOCATION PRODUCT
Ability Pharmaceuticals ABTL0815 Biodrugs/ Drugs Cancer Solid Tumors 1NRP ABTL0815
Therapeutic area: Cancer
Ability Pharmaceuticals ABTL1014 Biodrugs/ Drugs Blood and Lymphatic systems
Cancer
Leukaemia and Lymphomas 2RP ABTL1014
Therapeutic area: Blood and Lymphatic systems
Cancer
Ability Pharmaceuticals ABTL0812 Biodrugs/ Drugs Cancer Lung, Endometrial and Pancreatic Cancer 4PhII ABTL0812
Therapeutic area: Cancer
Almirall ADP31415 Biodrugs/ Drugs Autoimmune & Inflammation
Dermatology
Pemphigus Vulgaris 3PhI ADP31415
Therapeutic area: Autoimmune & Inflammation
Dermatology
Almirall ADP13612 Biodrugs/ Drugs Dermatology Rosacea 2RP ADP13612
Therapeutic area: Dermatology
Almirall LAS41010 Biodrugs/ Drugs Dermatology Atopic Dermatitis 6Reg. LAS41010
Therapeutic area: Dermatology
Almirall TIldrakizumab Biodrugs/ Drugs Autoimmune & Inflammation
Dermatology
Psoriasis 6Reg. TIldrakizumab
Therapeutic area: Autoimmune & Inflammation
Dermatology
Almirall ADP18998 Biodrugs/ Drugs Dermatology Actinic Keratosis 6Reg. ADP18998
Therapeutic area: Dermatology
Almirall P3058 Biodrugs/ Drugs Dermatology Onychomycosis 5PhIII P3058
Therapeutic area: Dermatology
Almirall P3070 Biodrugs/ Drugs Autoimmune & Inflammation
Dermatology
Nail Psoriasis 5PhIII P3070
Therapeutic area: Autoimmune & Inflammation
Dermatology
Almirall P3074 Biodrugs/ Drugs Dermatology Androgenetic Alopecia 5PhIII P3074
Therapeutic area: Dermatology
Almirall PAT001 Biodrugs/ Drugs Dermatology
Genetic Diseases and Dysmorphic syndromes
Ichthyosis 4PhII PAT001
Therapeutic area: Dermatology
Genetic Diseases and Dysmorphic syndromes
Almirall LAS 41008 Biodrugs/ Drugs Autoimmune & Inflammation
Dermatology
Psoriasis 6Reg. LAS 41008
Therapeutic area: Autoimmune & Inflammation
Dermatology
Aptatargets ApTOLL Biodrugs/ Drugs Cardiovascular and circulatory systems
Central Nervous System
Acute ischemic stroke Acute coronary syndrome Atherosclerosis 2RP ApTOLL
Therapeutic area: Cardiovascular and circulatory systems
Central Nervous System
APTUS Biotech ApTLR-4FT Biodrugs/ Drugs Central Nervous System Acute stroke 1NRP ApTLR-4FT
Therapeutic area: Central Nervous System
Araclon Biotech ABvac40 Biodrugs/ Drugs Central Nervous System Alzheimer's Disease 4PhII ABvac40
Therapeutic area: Central Nervous System
Archivel Farma RUTI® Vaccines Infections Active tuberculosis - Latent Tuberculosis 4PhII Europe and South Africa RUTI®
Therapeutic area: Infections
ATRYS HEALTH NILO1 Biodrugs/ Drugs Cancer
Central Nervous System
Brain tumor and brain lesions 1NRP Spain NILO1
Therapeutic area: Cancer
Central Nervous System
Bioibérica BIS014 Biodrugs/ Drugs Analgesia & Pain
Central Nervous System
Neuropathic pain 2RP Europe BIS014
Therapeutic area: Analgesia & Pain
Central Nervous System
Bionanoplus Psorio-Plus spray and gel Biodrugs/ Drugs Dermatology Help improving and soothing the manifestations of hyperkeratinized skins 2RP Psorio-Plus spray and gel
Therapeutic area: Dermatology
Bionanoplus Amorolfine Transungual Formulation Biodrugs/ Drugs Infections Onychomycosis 1NRP Amorolfine Transungual Formulation
Therapeutic area: Infections
Bionanoplus Ciclopirox Transungual Formulation Biodrugs/ Drugs Infections Onychomycosis 1NRP Ciclopirox Transungual Formulation
Therapeutic area: Infections
Bionanoplus CAX-LAST (Carbenoxolone mucoadhesive paste) Biodrugs/ Drugs Others Carbenoxolone paste for treatment of recurrent aphtous ulcers (RAS) (local mucosal delivery). 1NRP CAX-LAST (Carbenoxolone mucoadhesive paste)
Therapeutic area: Others
Bionanoplus Propylene Glycol Free Minoxidil Topical Formulation Biodrugs/ Drugs Dermatology Hair Loss 6Reg. Europe Propylene Glycol Free Minoxidil Topical Formulation
Therapeutic area: Dermatology
Bionanoplus Cyclosporine Topical Ophthalmic Formulation Biodrugs/ Drugs Ophthalmology and optometry Dry eye Syndrome 1NRP Cyclosporine Topical Ophthalmic Formulation
Therapeutic area: Ophthalmology and optometry
Bionanoplus MUCOZOL-LAST (Miconazole mucoadhesive paste) Biodrugs/ Drugs Others Anti-fungal Miconazole paste for buccal and oral delivery. 1NRP MUCOZOL-LAST (Miconazole mucoadhesive paste)
Therapeutic area: Others
Bionaturis BNT-014 Vaccines Infections Universal vaccine against common cold (rhinovirus) 1NRP BNT-014
Therapeutic area: Infections
Bionaturis BNT-001 Biodrugs/ Drugs Genetic Diseases and Dysmorphic syndromes Lysosomal storage diseases: Gaucher's disease. 1NRP BNT-001
Therapeutic area: Genetic Diseases and Dysmorphic syndromes
Bioncotech Therapeutics BO-110 Biodrugs/ Drugs Cancer Solid tumors 2RP Europe BO-110
Therapeutic area: Cancer
Bionure BN201 Biodrugs/ Drugs Central Nervous System
Ophthalmology and optometry
Acute Optic Neuritis, Neuromyelitis Optica, Multiple Sclerosis 3PhI BN201
Therapeutic area: Central Nervous System
Ophthalmology and optometry
DIOMUNE SL IV1303 Biodrugs/ Drugs Autoimmune & Inflammation
Cardiovascular and circulatory systems
Genetic Diseases and Dysmorphic syndromes
Infections
Sepsis treatment, Stroke, Rare diseases (CDH), Leishmania, ZIKV 2RP IV1303
Therapeutic area: Autoimmune & Inflammation
Cardiovascular and circulatory systems
Genetic Diseases and Dysmorphic syndromes
Infections
ENTRECHEM EC-70124 po for prostate cancer Biodrugs/ Drugs Cancer Castration resistant prostate cancer 2RP EC-70124 po for prostate cancer
Therapeutic area: Cancer
ENTRECHEM Brasilicardin analogs Biodrugs/ Drugs Autoimmune & Inflammation Immunosupression 1NRP Brasilicardin analogs
Therapeutic area: Autoimmune & Inflammation
ENTRECHEM EC-8042 iv for liposarcoma Biodrugs/ Drugs Cancer liposarcoma myxoide 2RP EC-8042 iv for liposarcoma
Therapeutic area: Cancer
ENTRECHEM EC-70124 po for AML Biodrugs/ Drugs Cancer Acute myeloid leukemia 2RP EC-70124 po for AML
Therapeutic area: Cancer
ENTRECHEM EC-8042 iv for Ewing sarcoma Biodrugs/ Drugs Cancer Solid tumours 2RP EC-8042 iv for Ewing sarcoma
Therapeutic area: Cancer
ENTRECHEM EC-8042 iv for Triple negative breast cancer Biodrugs/ Drugs Cancer Triple negative breast cancer 2RP EC-8042 iv for Triple negative breast cancer
Therapeutic area: Cancer
ENTRECHEM EC-70124 po for TNBC Biodrugs/ Drugs Cancer Triple negative breast cancer 2RP EC-70124 po for TNBC
Therapeutic area: Cancer
ESTEVE EGT-101 Gene / Cell Therapy Genetic Diseases and Dysmorphic syndromes Sanfilippo A syndrome:Lysosomal storage rare disease 2RP EGT-101
Therapeutic area: Genetic Diseases and Dysmorphic syndromes
ESTEVE E-52862 Biodrugs/ Drugs Analgesia & Pain Neuropathic Pain 4PhII E-52862
Therapeutic area: Analgesia & Pain
ESTEVE E-58425 Biodrugs/ Drugs Analgesia & Pain Acute and chronic, moderate to severe pain 4PhII E-58425
Therapeutic area: Analgesia & Pain
ESTEVE HIVACAT Biodrugs/ Drugs Infections Prophylactic- Therapeutic HIV vaccine 3PhI HIVACAT
Therapeutic area: Infections
ESTEVE EGT-301 Gene / Cell Therapy Genetic Diseases and Dysmorphic syndromes Hunter syndrome: Lysosomal storage disease 1NRP EGT-301
Therapeutic area: Genetic Diseases and Dysmorphic syndromes
ESTEVE MUMO1 Biodrugs/ Drugs Analgesia & Pain Acute and chronic, moderate to severe pain 2RP MUMO1
Therapeutic area: Analgesia & Pain
ESTEVE EGT-201 Gene / Cell Therapy Genetic Diseases and Dysmorphic syndromes Sanfilippo B syndrome: Lisosomal storage rare disease 1NRP EGT-201
Therapeutic area: Genetic Diseases and Dysmorphic syndromes
FECYT Pylori Biodrugs/ Drugs Infections H. pylori 2RP Pylori
Therapeutic area: Infections
FECYT p300 Biodrugs/ Drugs Cancer Cancer 2RP p300
Therapeutic area: Cancer
FECYT p38 Biodrugs/ Drugs Analgesia & Pain
Central Nervous System
Neuropathic Pain 2RP p38
Therapeutic area: Analgesia & Pain
Central Nervous System
FERRER Ozenoxacin Biodrugs/ Drugs Dermatology
Infections
Dermal infections 6Reg. Ozenoxacin
Therapeutic area: Dermatology
Infections
FERRER FAB-120 Biodrugs/ Drugs Ophthalmology and optometry Diabetic Retinopathy 2RP FAB-120
Therapeutic area: Ophthalmology and optometry
FERRER Lorediplon Biodrugs/ Drugs Central Nervous System Sleep disorders 4PhII Lorediplon
Therapeutic area: Central Nervous System
FERRER FAB-117 Gene / Cell Therapy Central Nervous System Spinal Cord Injury 3PhI FAB-117
Therapeutic area: Central Nervous System
FERRER FAB-112 Gene / Cell Therapy Ophthalmology and optometry Corneal Diseases 2RP FAB-112
Therapeutic area: Ophthalmology and optometry
FIBROSTATIN FSSME12 Biodrugs/ Drugs Cancer Lung and Breast Cancer 2RP Europe FSSME12
Therapeutic area: Cancer
FIBROSTATIN FSMAB26 Biodrugs/ Drugs Autoimmune & Inflammation
Kidney and Genitourinary system
Lupus nephritis 1NRP Europe FSMAB26
Therapeutic area: Autoimmune & Inflammation
Kidney and Genitourinary system
FUND. PROGRESO Y SALUD / IATA (SAS) FIBAO-13007 Gene / Cell Therapy Cancer Cancer cells 2RP Europe FIBAO-13007
Therapeutic area: Cancer
FUND. PROGRESO Y SALUD / IATA (SAS) Engineered Corneas Gene / Cell Therapy Ophthalmology and optometry Corneal ulcers 4PhII Europe Engineered Corneas
Therapeutic area: Ophthalmology and optometry
FUND. PROGRESO Y SALUD / IATA (SAS) Autologous Bone Marrow Mononuclear cells Gene / Cell Therapy Cardiovascular and circulatory systems
Metabolic / Endocrinology
Critical Limb Ischemia in diabetic patients 3PhI Worldwide Autologous Bone Marrow Mononuclear cells
Therapeutic area: Cardiovascular and circulatory systems
Metabolic / Endocrinology
FUND. PROGRESO Y SALUD / IATA (SAS) Autologous Bone Marrow progenitors, Adipose and Bone Marrow Mesenchymal stem cells Gene / Cell Therapy Autoimmune & Inflammation
Central Nervous System
Stroke, Multiple Sclerosis and ALS 4PhII Europe Autologous Bone Marrow progenitors, Adipose and Bone Marrow Mesenchymal stem cells
Therapeutic area: Autoimmune & Inflammation
Central Nervous System
FUND. PROGRESO Y SALUD / IATA (SAS) Autologous Bone Marrow Mononuclear cells and Adipose Mesenchymal stem cells Gene / Cell Therapy Digestive System Extended Liver resection, Faecal Incontinence 4PhII Europe Autologous Bone Marrow Mononuclear cells and Adipose Mesenchymal stem cells
Therapeutic area: Digestive System
FUND. PROGRESO Y SALUD / IATA (SAS) Autologous Bone Marrow Mononuclear cells Gene / Cell Therapy Cardiovascular and circulatory systems
Metabolic / Endocrinology
Acute Myocardial Infarction/Dilated Myocardiopathy/Chronic Ischemic Cardiopathy/Critical Limb Ischemia in diabetic & non patients 4PhII Europe Autologous Bone Marrow Mononuclear cells
Therapeutic area: Cardiovascular and circulatory systems
Metabolic / Endocrinology
FUND. PROGRESO Y SALUD / IATA (SAS) Allogeneic Adipose Mesenchymal stem cells / Allodepleted Bone Marrow Progenitors Biodrugs/ Drugs Autoimmune & Inflammation
Blood and Lymphatic systems
Chronic Graft versus Host Disease, Haematological Malignancies 4PhII Europe Allogeneic Adipose Mesenchymal stem cells / Allodepleted Bone Marrow Progenitors
Therapeutic area: Autoimmune & Inflammation
Blood and Lymphatic systems
FUND. PROGRESO Y SALUD / OTT (SAS) FIBAO-116 Biodrugs/ Drugs Analgesia & Pain Fibromyalgia 3PhI FIBAO-116
Therapeutic area: Analgesia & Pain
FUND. PROGRESO Y SALUD / OTT (SAS) FIMABIS-99 Biodrugs/ Drugs Metabolic / Endocrinology Nanoemulsions for the treatment of obesity 2RP FIMABIS-99
Therapeutic area: Metabolic / Endocrinology
FUND. PROGRESO Y SALUD / OTT (SAS) FIMABIS-13001 Biodrugs/ Drugs Metabolic / Endocrinology Treatment and/or Prevention of Non-alcoholic fatty liver disease (NAFLD) 2RP FIMABIS-13001
Therapeutic area: Metabolic / Endocrinology
FUND. PROGRESO Y SALUD / OTT (SAS) FIMABIS-77 Biodrugs/ Drugs Central Nervous System Hydroxytyrosol ethers 2RP FIMABIS-77
Therapeutic area: Central Nervous System
FUND. PROGRESO Y SALUD / OTT (SAS) FIMABIS-13007 Biodrugs/ Drugs Cardiovascular and circulatory systems
Metabolic / Endocrinology
Treatment and/or prevention of metabolic and cardiovascular diseases 2RP FIMABIS-13007
Therapeutic area: Cardiovascular and circulatory systems
Metabolic / Endocrinology
FUND. PROGRESO Y SALUD / OTT (SAS) FIMABIS-13007 Biodrugs/ Drugs Cardiovascular and circulatory systems
Metabolic / Endocrinology
Treatment and/or Prevention of cardiovascular and metabolic diseases 2RP FIMABIS-13007
Therapeutic area: Cardiovascular and circulatory systems
Metabolic / Endocrinology
FUND. PROGRESO Y SALUD / OTT (SAS) FISEVI-14012 Biodrugs/ Drugs Infections Multirresistant infections 2RP Europe FISEVI-14012
Therapeutic area: Infections
FUND. PROGRESO Y SALUD / OTT (SAS) FISEVI-13007 Gene / Cell Therapy Cancer Hepatocarcinoma 2RP Europe FISEVI-13007
Therapeutic area: Cancer
FUND. PROGRESO Y SALUD / OTT (SAS) FIMABIS-14003 Biodrugs/ Drugs Dermatology
Infections
Treatment of mucocutaneous herpes infections 4PhII Europe FIMABIS-14003
Therapeutic area: Dermatology
Infections
FUND. PROGRESO Y SALUD / OTT (SAS) FRM-5 Gene / Cell Therapy Others Transplant 2RP Europe FRM-5
Therapeutic area: Others
FUND. PROGRESO Y SALUD / OTT (SAS) CABIMER-14001 Condon plasma factors for skin regeneration Gene / Cell Therapy Autoimmune & Inflammation
Dermatology
Dermatitis 1NRP Worldwide CABIMER-14001 Condon plasma factors for skin regeneration
Therapeutic area: Autoimmune & Inflammation
Dermatology
FUND. PROGRESO Y SALUD / OTT (SAS) FISEVI-13020 Biodrugs/ Drugs Central Nervous System Alzheimer's disease 2RP Europe FISEVI-13020
Therapeutic area: Central Nervous System
FUND. PROGRESO Y SALUD / OTT (SAS) CABIMER-11 New target gene and delivery systems for the Treatment of Retinitis Pigmentosa Gene / Cell Therapy Ophthalmology and optometry Retinitis pigmentosa 1NRP Worldwide CABIMER-11 New target gene and delivery systems for the Treatment of Retinitis Pigmentosa
Therapeutic area: Ophthalmology and optometry
FUND. PROGRESO Y SALUD / OTT (SAS) FISEVI 141 Biodrugs/ Drugs Infections Sepsis, Acute lung injury 2RP Europe FISEVI 141
Therapeutic area: Infections
FUND. PROGRESO Y SALUD / OTT (SAS) CABIMER-13003 Vaccines Central Nervous System Parkinson 1NRP Worldwide CABIMER-13003
Therapeutic area: Central Nervous System
FUND. PROGRESO Y SALUD / OTT (SAS) FISEVI-13002 Biodrugs/ Drugs Cancer Multiple myeloma 2RP Europe FISEVI-13002
Therapeutic area: Cancer
FUND. PROGRESO Y SALUD / OTT (SAS) FIBICO-14003 Gene / Cell Therapy Musculoskeletal Disorders Musculoskeletal disorders 1NRP FIBICO-14003
Therapeutic area: Musculoskeletal Disorders
FUND. PROGRESO Y SALUD / OTT (SAS) FIBAO-91 Melatonine Solution Biodrugs/ Drugs Infections Sepsis 4PhII FIBAO-91 Melatonine Solution
Therapeutic area: Infections
FUND. PROGRESO Y SALUD / OTT (SAS) FISEVI-121 Gene / Cell Therapy Autoimmune & Inflammation Transplant 2RP Europe FISEVI-121
Therapeutic area: Autoimmune & Inflammation
FUND. PROGRESO Y SALUD / OTT (SAS) FIBICO-14002 Biodrugs/ Drugs Cancer Metastatic processes and resistant cancers 1NRP FIBICO-14002
Therapeutic area: Cancer
FUND. PROGRESO Y SALUD / OTT (SAS) FIBAO-13014 Combination of Ketamine and Meperidine Biodrugs/ Drugs Autoimmune & Inflammation
Autoimmune & Inflammation
Mucositis 3PhI FIBAO-13014 Combination of Ketamine and Meperidine
Therapeutic area: Autoimmune & Inflammation
Autoimmune & Inflammation
FUNDACIÓN JIMÉNEZ DÍAZ (Instituto de Investigación Sanitaria) New generation of peptides Biodrugs/ Drugs Autoimmune & Inflammation
Blood and Lymphatic systems
Cardiovascular and circulatory systems
Kidney and Genitourinary system
Metabolic / Endocrinology
Ophthalmology and optometry
Chronic complications of Diabetes 2RP New generation of peptides
Therapeutic area: Autoimmune & Inflammation
Blood and Lymphatic systems
Cardiovascular and circulatory systems
Kidney and Genitourinary system
Metabolic / Endocrinology
Ophthalmology and optometry
FUNDACIÓN JIMÉNEZ DÍAZ (Instituto de Investigación Sanitaria) Peptide derived from a natural compound Biodrugs/ Drugs Autoimmune & Inflammation
Metabolic / Endocrinology
Osteoporosis treatment 1NRP Peptide derived from a natural compound
Therapeutic area: Autoimmune & Inflammation
Metabolic / Endocrinology
FUNDACIÓN JIMÉNEZ DÍAZ (Instituto de Investigación Sanitaria) Mutli-target siRNA approach Gene / Cell Therapy Autoimmune & Inflammation
Kidney and Genitourinary system
Chronic Kidney Disease (CKD)/ Akute Kidney Injury (AKI) 2RP Mutli-target siRNA approach
Therapeutic area: Autoimmune & Inflammation
Kidney and Genitourinary system
Fundacion MEDINA MDN-0109, MDN-110, MDN-111, MDN- 112 Biodrugs/ Drugs Infections Malaria 1NRP MDN-0109, MDN-110, MDN-111, MDN- 112
Therapeutic area: Infections
Fundacion MEDINA MDN-0090 Biodrugs/ Drugs Cancer Pancreatic Cancer 1NRP MDN-0090
Therapeutic area: Cancer
Fundacion MEDINA MDN-005 Biodrugs/ Drugs Central Nervous System
Musculoskeletal Disorders
Amyotrophic lateral sclerosis (ALS) 1NRP MDN-005
Therapeutic area: Central Nervous System
Musculoskeletal Disorders
Fundacion MEDINA MDN-088 Biodrugs/ Drugs Cancer Breast, Colon & Lung Cancer 1NRP MDN-088
Therapeutic area: Cancer
Fundacion MEDINA MDN-018 Biodrugs/ Drugs Infections Fungal Infections 1NRP MDN-018
Therapeutic area: Infections
Fundacion MEDINA MDN-057/MDN-058/MDN-059 Biodrugs/ Drugs Infections Gram negative infections 1NRP MDN-057/MDN-058/MDN-059
Therapeutic area: Infections
Fundacion MEDINA MDN-0145; MDN-0146 Biodrugs/ Drugs Central Nervous System Parkinson 1NRP MDN-0145; MDN-0146
Therapeutic area: Central Nervous System
Fundacion MEDINA MDN-0147; MDN-0148 & MDN-0149 Biodrugs/ Drugs Cancer Melanoma 1NRP MDN-0147; MDN-0148 & MDN-0149
Therapeutic area: Cancer
Genmedica Therapeutics GMC-252 Biodrugs/ Drugs Metabolic / Endocrinology Type 2 Diabetes 3PhI Europe GMC-252
Therapeutic area: Metabolic / Endocrinology
GP-PHARM Triptorelina Depot 1-3 Biodrugs/ Drugs Cancer Prostate Cancer 3PhI Europe and Latinamerica Triptorelina Depot 1-3
Therapeutic area: Cancer
GP-PHARM Risperidona Depot Biodrugs/ Drugs Central Nervous System Schizophrenia 2RP Worldwide Risperidona Depot
Therapeutic area: Central Nervous System
GP-PHARM Octeotride MAR Biodrugs/ Drugs Cancer
Digestive System
Acute diarrhoea post chemotherapy 3PhI Worldwide Octeotride MAR
Therapeutic area: Cancer
Digestive System
GP-PHARM Lutrate Depot 45 mg Biodrugs/ Drugs Cancer Prostate Cancer 3PhI Worldwide Lutrate Depot 45 mg
Therapeutic area: Cancer
GP-PHARM Octeotride LAR Biodrugs/ Drugs Metabolic / Endocrinology Acromegaly 4PhII Worldwide Octeotride LAR
Therapeutic area: Metabolic / Endocrinology
GP-PHARM Lutrate Depot 22,5 mg Biodrugs/ Drugs Cancer Prostate Cancer 6Reg. Lutrate Depot 22,5 mg
Therapeutic area: Cancer
GP-PHARM Pegylated Liposomes for Oncology Biodrugs/ Drugs Cancer Advanced Ovarian Cancer, Advanced Breast Cancer 3PhI Worldwide Pegylated Liposomes for Oncology
Therapeutic area: Cancer
GP-PHARM TERIPERATIDE Biodrugs/ Drugs Musculoskeletal Disorders Osteoporosis 3PhI TERIPERATIDE
Therapeutic area: Musculoskeletal Disorders
GP-PHARM Desmopresina Solution Biodrugs/ Drugs Kidney and Genitourinary system Nocturnal Enuresis 6Reg. Desmopresina Solution
Therapeutic area: Kidney and Genitourinary system
GP-PHARM depot form. Biodrugs/ Drugs Cancer Several 3PhI depot form.
Therapeutic area: Cancer
Histocell HR004 Biodrugs/ Drugs Musculoskeletal Disorders Bone Regeneration 4PhII HR004
Therapeutic area: Musculoskeletal Disorders
Histocell HR016 Biodrugs/ Drugs Respiratory and Pulmonary system Acute Lung Injury 2RP HR016
Therapeutic area: Respiratory and Pulmonary system
Histocell HC016 Biodrugs/ Drugs Central Nervous System Acute Spinal Cord Injury 4PhII HC016
Therapeutic area: Central Nervous System
InKemia IUCT group IUCT-DS-0423 Biodrugs/ Drugs Cancer Prostate cancer 1NRP IUCT-DS-0423
Therapeutic area: Cancer
InKemia IUCT group DIS-COM-TROP Biodrugs/ Drugs Central Nervous System Migraine 1NRP DIS-COM-TROP
Therapeutic area: Central Nervous System
InKemia IUCT group IUCT-DS-0347 Biodrugs/ Drugs Cancer Prostate cancer 1NRP Europe IUCT-DS-0347
Therapeutic area: Cancer
InKemia IUCT group DIS-COM-BRA Biodrugs/ Drugs Respiratory and Pulmonary system Asthma 1NRP DIS-COM-BRA
Therapeutic area: Respiratory and Pulmonary system
InKemia IUCT group IUCT-DS-0263 Biodrugs/ Drugs Cancer Prostate cancer 1NRP Europe IUCT-DS-0263
Therapeutic area: Cancer
InKemia IUCT group DIS-COM-BRA Biodrugs/ Drugs Analgesia & Pain
Autoimmune & Inflammation
Inflammation 1NRP DIS-COM-BRA
Therapeutic area: Analgesia & Pain
Autoimmune & Inflammation
InKemia IUCT group IUCT-DS-0423 Biodrugs/ Drugs Cancer Breast cancer 1NRP IUCT-DS-0423
Therapeutic area: Cancer
InKemia IUCT group IUCT-DS-0347 Biodrugs/ Drugs Cancer Breast cancer 1NRP IUCT-DS-0347
Therapeutic area: Cancer
InKemia IUCT group IUCT-DS-0263 Biodrugs/ Drugs Cancer Breast cancer 1NRP IUCT-DS-0263
Therapeutic area: Cancer
InKemia IUCT group IUCT-DS-0086 Biodrugs/ Drugs Cancer Breast cancer 1NRP IUCT-DS-0086
Therapeutic area: Cancer
InKemia IUCT group DIS-COM-COAG Biodrugs/ Drugs Cardiovascular and circulatory systems Anticoagulants 1NRP DIS-COM-COAG
Therapeutic area: Cardiovascular and circulatory systems
InKemia IUCT group DIS-BIO-EPS Biodrugs/ Drugs Analgesia & Pain
Autoimmune & Inflammation
Osteoarthritis 1NRP DIS-BIO-EPS
Therapeutic area: Analgesia & Pain
Autoimmune & Inflammation
InKemia IUCT group DIS-BIO-VIR Biodrugs/ Drugs Infections Antivirals 1NRP DIS-BIO-VIR
Therapeutic area: Infections
InKemia IUCT group DIS-BIO-CAN Biodrugs/ Drugs Cancer Antineoplastic 1NRP DIS-BIO-CAN
Therapeutic area: Cancer
Institut Quimic de Sarrià (IQS) Chondro-implant Gene / Cell Therapy Cardiovascular and circulatory systems Bioactive implant for myocardial regeneration, ventricular support and elliptical shape restoration. Acute Cartilage Injure 1NRP Chondro-implant
Therapeutic area: Cardiovascular and circulatory systems
Institut Quimic de Sarrià (IQS) Cardio-implant Gene / Cell Therapy Cardiovascular and circulatory systems PCL (Polycaprolactone), SAP (self-assembling peptide) bioactive and biomimetic scaffolds for cartilage regeneration. Heart infarct 1NRP Cardio-implant
Therapeutic area: Cardiovascular and circulatory systems
Iproteos IPR-166 Biodrugs/ Drugs Central Nervous System Cognitive Impairment Associated with Schizophrenia (CIAS) 2RP IPR-166
Therapeutic area: Central Nervous System
Iproteos IPR-179 Biodrugs/ Drugs Central Nervous System Epilepsy 1NRP IPR-179
Therapeutic area: Central Nervous System
IRYCIS New compound for the treatment of isquemical stroke Biodrugs/ Drugs Central Nervous System Isquemic stroke 1NRP Spain New compound for the treatment of isquemical stroke
Therapeutic area: Central Nervous System
Lipopharma Therapeutics LP204A1 Biodrugs/ Drugs Autoimmune & Inflammation Inflammation 1NRP LP204A1
Therapeutic area: Autoimmune & Inflammation
Lipopharma Therapeutics LP561A1 Biodrugs/ Drugs Cancer Glioma and other solid tumours 4PhII LP561A1
Therapeutic area: Cancer
Lipopharma Therapeutics LP226A1 Biodrugs/ Drugs Central Nervous System Alzheimer's Disease 2RP Europe LP226A1
Therapeutic area: Central Nervous System
Lipopharma Therapeutics LP30171 Biodrugs/ Drugs Metabolic / Endocrinology Metabolic Diseases 1NRP LP30171
Therapeutic area: Metabolic / Endocrinology
Lipopharma Therapeutics LP205A1 Biodrugs/ Drugs Cardiovascular and circulatory systems
Metabolic / Endocrinology
Cardiovascular and Metabolic Diseases 1NRP Europe LP205A1
Therapeutic area: Cardiovascular and circulatory systems
Metabolic / Endocrinology
Lipopharma Therapeutics LPA181 Biodrugs/ Drugs Central Nervous System Spinal Cord Injuries 1NRP LPA181
Therapeutic area: Central Nervous System
Minoryx MIN101 Biodrugs/ Drugs Central Nervous System
Genetic Diseases and Dysmorphic syndromes
Metabolic / Endocrinology
Adrenoleukodystrophy 2RP MIN101
Therapeutic area: Central Nervous System
Genetic Diseases and Dysmorphic syndromes
Metabolic / Endocrinology
Minoryx MIN-102 Biodrugs/ Drugs Central Nervous System
Metabolic / Endocrinology
X-linked Adrenoleukodystrophy 3PhI MIN-102
Therapeutic area: Central Nervous System
Metabolic / Endocrinology
NATAC Retriacyl Biodrugs/ Drugs Ophthalmology and optometry Retinitis Pigmentosa 5PhIII Europe Retriacyl
Therapeutic area: Ophthalmology and optometry
Neuron Bio NPS0158 Biodrugs/ Drugs Central Nervous System Mild Cognitive Impairment 1NRP Europe NPS0158
Therapeutic area: Central Nervous System
Neuron Bio NPS0163 Biodrugs/ Drugs Central Nervous System Mild Cognitive Impairment 1NRP Europe NPS0163
Therapeutic area: Central Nervous System
Neuron Bio NST0078 Biodrugs/ Drugs Central Nervous System Mild Cognitive Impairment / Epilepsy 1NRP Europe NST0078
Therapeutic area: Central Nervous System
Neuron Bio NST0076 Biodrugs/ Drugs Central Nervous System Mild Cognitive Impairment / Epilepsy 1NRP Europe NST0076
Therapeutic area: Central Nervous System
Neuron Bio NST0037 Biodrugs/ Drugs Central Nervous System Mild Cognitive Impairment / Epilepsy 2RP Europe NST0037
Therapeutic area: Central Nervous System
nLife Therapeutics, S.L. NLF-PD-1233 Biodrugs/ Drugs Central Nervous System Parkinson Disease 2RP Europe and USA NLF-PD-1233
Therapeutic area: Central Nervous System
Oryzon ORY-3001 Biodrugs/ Drugs Others Non-oncological disease 2RP ORY-3001
Therapeutic area: Others
Oryzon ORY-1001 Biodrugs/ Drugs Blood and Lymphatic systems
Cancer
Acute Myeloid Leukaemia, Solid tumors, Other oncohaematology indications 3PhI ORY-1001
Therapeutic area: Blood and Lymphatic systems
Cancer
Oryzon OG-new series in KDM Biodrugs/ Drugs Cancer
Others
Solid cancers, Oncohaematology 1NRP OG-new series in KDM
Therapeutic area: Cancer
Others
Oryzon ORY-2001 Biodrugs/ Drugs Central Nervous System Alzheimer's disease, Multiple Sclerosis, Huntington's disease, other dementias, 3PhI ORY-2001
Therapeutic area: Central Nervous System
PaloBiofarma PBF-695 Biodrugs/ Drugs Ophthalmology and optometry Glaucoma 2RP PBF-695
Therapeutic area: Ophthalmology and optometry
PaloBiofarma PBF-999 Biodrugs/ Drugs Central Nervous System Huntington Disease 2RP PBF-999
Therapeutic area: Central Nervous System
PaloBiofarma PBF-509 Biodrugs/ Drugs Cancer
Central Nervous System
Attention-Deficit, Hyperactivity Disorder (ADHD), Lung Cancer 3PhI PBF-509
Therapeutic area: Cancer
Central Nervous System
PaloBiofarma PBF680 Biodrugs/ Drugs Respiratory and Pulmonary system Asthma 3PhI PBF680
Therapeutic area: Respiratory and Pulmonary system
PANGAEA ONCOLOGY PB1 Biodrugs/ Drugs Cancer CNS, Neuroderived tumours, Local delivery 1NRP PB1
Therapeutic area: Cancer
Pevesa PEV pept. 01-02 Biodrugs/ Drugs Metabolic / Endocrinology Metabolic Syndrome 2RP Europe PEV pept. 01-02
Therapeutic area: Metabolic / Endocrinology
PharmaMar Lurbinectedin Biodrugs/ Drugs Cancer Platinum-Resistant Ovarian Cancer 5PhIII Lurbinectedin
Therapeutic area: Cancer
PharmaMar Aplidin Biodrugs/ Drugs Cancer Multiple Myeloma 5PhIII Aplidin
Therapeutic area: Cancer
PharmaMar Aplidin Biodrugs/ Drugs Blood and Lymphatic systems
Cancer
T Cell Lymphoma 4PhII Aplidin
Therapeutic area: Blood and Lymphatic systems
Cancer
PharmaMar Aplidin Biodrugs/ Drugs Cancer Multiple Myeloma in combination with bortezomid 4PhII Aplidin
Therapeutic area: Cancer
PharmaMar Lurbinectedin Biodrugs/ Drugs Cancer Combination trials 3PhI Lurbinectedin
Therapeutic area: Cancer
PharmaMar PM184 Biodrugs/ Drugs Cancer Combination trials 3PhI PM184
Therapeutic area: Cancer
PharmaMar Lurbinectedin Biodrugs/ Drugs Cancer Small Cell Lung Cancer 5PhIII Lurbinectedin
Therapeutic area: Cancer
PharmaMar Lurbinectedin Biodrugs/ Drugs Cancer Basket trial 4PhII Lurbinectedin
Therapeutic area: Cancer
PharmaMar PM184 Biodrugs/ Drugs Cancer Advanced Breast cancer 4PhII PM184
Therapeutic area: Cancer
PharmaMar Lurbinectedin Biodrugs/ Drugs Cancer BRCA Associated Breast Cancer 4PhII Lurbinectedin
Therapeutic area: Cancer
PRAXIS NANOPLATFORMM Biodrugs/ Drugs Infections NANOFORMULATION OF DRUGS FOR RESISTANT INFECTIONS 1NRP NANOPLATFORMM
Therapeutic area: Infections
PRAXIS EPIPROT Biodrugs/ Drugs Dermatology Diabetic Foot 5PhIII EPIPROT
Therapeutic area: Dermatology
PRAXIS NANOENZHIMES Biodrugs/ Drugs Genetic Diseases and Dysmorphic syndromes SANFILIPPO/FABRY 1NRP NANOENZHIMES
Therapeutic area: Genetic Diseases and Dysmorphic syndromes
PRAXIS NNE Biodrugs/ Drugs Dermatology Diabetic Foot 1NRP NNE
Therapeutic area: Dermatology
PRAXIS TAT-CF Biodrugs/ Drugs Genetic Diseases and Dysmorphic syndromes CYSTIC FIBROSIS 1NRP TAT-CF
Therapeutic area: Genetic Diseases and Dysmorphic syndromes
PRAXIS TERFIQEC Gene / Cell Therapy Genetic Diseases and Dysmorphic syndromes Cystic Fibrosis 2RP TERFIQEC
Therapeutic area: Genetic Diseases and Dysmorphic syndromes
PRAXIS NANOCANTHER Biodrugs/ Drugs Cancer THERAPY SYSTEMS FOR PANCREATIC CANCER 1NRP NANOCANTHER
Therapeutic area: Cancer
PRAXIS Fibrodress Biodrugs/ Drugs Central Nervous System Dressing for Neuropathic bounds 2RP Fibrodress
Therapeutic area: Central Nervous System
PRAXIS LP561A1 Biodrugs/ Drugs Cancer GLIOMA 4PhII LP561A1
Therapeutic area: Cancer
PRAXIS BIOTCARM Biodrugs/ Drugs Cancer GLIOMA 4PhII BIOTCARM
Therapeutic area: Cancer
PRAXIS PROHEAL Biodrugs/ Drugs Dermatology Bioactive wound dressings (Diabetic / vascular) 2RP PROHEAL
Therapeutic area: Dermatology
PRAXIS Nanoantibiotics Gene / Cell Therapy Respiratory and Pulmonary system Resistent Infections (Cystic Fibrosis) 1NRP Nanoantibiotics
Therapeutic area: Respiratory and Pulmonary system
PRAXIS ANTIAGE Biodrugs/ Drugs Dermatology ANTIAGING DRUGS AND NUTRACEUTICS 2RP ANTIAGE
Therapeutic area: Dermatology
PRAXIS BIOTCATM Biodrugs/ Drugs Cancer Cancer 1NRP BIOTCATM
Therapeutic area: Cancer
PRAXIS OLEA Biodrugs/ Drugs Dermatology ANTIAGING DRUGS AND NUTRACEUTICS 2RP OLEA
Therapeutic area: Dermatology
PRAXIS BERENICE Biodrugs/ Drugs Genetic Diseases and Dysmorphic syndromes Chagas 5PhIII BERENICE
Therapeutic area: Genetic Diseases and Dysmorphic syndromes
PRAXIS ALZHEIMER Biodrugs/ Drugs Central Nervous System ALZHEIMER 1NRP ALZHEIMER
Therapeutic area: Central Nervous System
PRAXIS TERARMET Biodrugs/ Drugs Others SANFILIPPO 1NRP TERARMET
Therapeutic area: Others
REIG JOFRE Bioadhesive topical gel Biodrugs/ Drugs Dermatology Impetigo, skin infections 5PhIII Bioadhesive topical gel
Therapeutic area: Dermatology
REIG JOFRE/LABORATORIOS MEDEA Topical solution Biodrugs/ Drugs Dermatology Skyn infection 5PhIII Topical solution
Therapeutic area: Dermatology
Sanifit SNF472 Biodrugs/ Drugs Cardiovascular and circulatory systems
Metabolic / Endocrinology
Cardiovascular disease (dialysis) 4PhII SNF472
Therapeutic area: Cardiovascular and circulatory systems
Metabolic / Endocrinology
Sanifit SNF472 Biodrugs/ Drugs Cardiovascular and circulatory systems
Metabolic / Endocrinology
Calciphylaxis (dialysis) 4PhII SNF472
Therapeutic area: Cardiovascular and circulatory systems
Metabolic / Endocrinology
SOM Biotech SOM0226 Biodrugs/ Drugs Central Nervous System
Genetic Diseases and Dysmorphic syndromes
Metabolic / Endocrinology
All Types of Transthyretin Amyloidosis: Familial Amyloid Polyneuropathy, Familial Amyloid Cardiomyopathy, Senile Systemic Amyloidosis, Ophthalmic and CNS forms. 5PhIII SOM0226
Therapeutic area: Central Nervous System
Genetic Diseases and Dysmorphic syndromes
Metabolic / Endocrinology
SOM Biotech SOM3355 Biodrugs/ Drugs Central Nervous System
Genetic Diseases and Dysmorphic syndromes
Huntington's disease, Tourette syndrome and Tardive Dyskinesia 4PhII SOM3355
Therapeutic area: Central Nervous System
Genetic Diseases and Dysmorphic syndromes
SOM Biotech SOM1201 Biodrugs/ Drugs Central Nervous System
Genetic Diseases and Dysmorphic syndromes
Adrenoleukodystrophy 4PhII SOM1201
Therapeutic area: Central Nervous System
Genetic Diseases and Dysmorphic syndromes
SOM Biotech SOM0777 Biodrugs/ Drugs Cancer Glioblastoma 1NRP SOM0777
Therapeutic area: Cancer
SOM Biotech SOM2201 Biodrugs/ Drugs Central Nervous System
Genetic Diseases and Dysmorphic syndromes
Musculoskeletal Disorders
Duchenne Muscular Dystrophy 1NRP SOM2201
Therapeutic area: Central Nervous System
Genetic Diseases and Dysmorphic syndromes
Musculoskeletal Disorders
SPHERIUM BIOMED S.L SP15016 Biodrugs/ Drugs Cardiovascular and circulatory systems
Kidney and Genitourinary system
Prevention of Acute Kidney Injury in Angioplasty patients receiving high dose contrast agent 2RP SP15016
Therapeutic area: Cardiovascular and circulatory systems
Kidney and Genitourinary system
SPHERIUM BIOMED S.L SP13004 Biodrugs/ Drugs Cancer
Dermatology
Digestive System
Prevention and treatment of radiochemotherapy-induced mucositis in head and neck cancer 4PhII SP13004
Therapeutic area: Cancer
Dermatology
Digestive System
SPHERIUM BIOMED S.L SP12006 Biodrugs/ Drugs Analgesia & Pain
Musculoskeletal Disorders
Treatment of mild to moderate muscular pain (related to sportive practice DOMS and Temporomandibular Joint Disorder) 4PhII SP12006
Therapeutic area: Analgesia & Pain
Musculoskeletal Disorders
SPHERIUM BIOMED S.L SP14019 Biodrugs/ Drugs Dermatology topical spray of cyclosporine to treat Atopic Dermatitis & Psoriasis 4PhII SP14019
Therapeutic area: Dermatology
Stem Center S.L.U. GID SVF-1 Gene / Cell Therapy Others Plastic and reconstructive surgery 6Reg. Europe GID SVF-1
Therapeutic area: Others
Sylentis siRNA Biodrugs/ Drugs Ophthalmology and optometry Ocular Allergy 2RP siRNA
Therapeutic area: Ophthalmology and optometry
Sylentis SYL1001 Biodrugs/ Drugs Ophthalmology and optometry Dry Eye Syndrome 5PhIII SYL1001
Therapeutic area: Ophthalmology and optometry
Sylentis Bamosiran/SYL040012 Biodrugs/ Drugs Ophthalmology and optometry Ocular Hypertension, Glaucoma 4PhII Bamosiran/SYL040012
Therapeutic area: Ophthalmology and optometry
Sylentis siRNA Biodrugs/ Drugs Autoimmune & Inflammation
Digestive System
Crohn's disease and ulcerative colitis 2RP siRNA
Therapeutic area: Autoimmune & Inflammation
Digestive System
TERACLON IDF T1649 Biodrugs/ Drugs Autoimmune & Inflammation
Dermatology
Psoriasis 1NRP T1649
Therapeutic area: Autoimmune & Inflammation
Dermatology
TERACLON IDF V-32-R Biodrugs/ Drugs Ophthalmology and optometry Glaucoma 2RP V-32-R
Therapeutic area: Ophthalmology and optometry
TERACLON IDF V32R Biodrugs/ Drugs Ophthalmology and optometry Diabetic Retinopathy 2RP V32R
Therapeutic area: Ophthalmology and optometry
Thrombotargets TT-112 Biodrugs/ Drugs Blood and Lymphatic systems Antifibrinolysis 1NRP TT-112
Therapeutic area: Blood and Lymphatic systems
Thrombotargets TT-173 Biodrugs/ Drugs Blood and Lymphatic systems Haemorrhage 5PhIII TT-173
Therapeutic area: Blood and Lymphatic systems
VCN Biosciences VCN-01 Gene / Cell Therapy Cancer Pancreatic cancer 3PhI Europe VCN-01
Therapeutic area: Cancer
VCN Biosciences VCN-02 Gene / Cell Therapy Cancer Solid Tumors 1NRP VCN-02
Therapeutic area: Cancer
VENTER PHARMA LacTEST Biodrugs/ Drugs Digestive System Evaluation of hypolactasia 6Reg. LacTEST
Therapeutic area: Digestive System
Vivacell Biotechnology Espa VCE-003.2 Biodrugs/ Drugs Central Nervous System Huntington Disease 1NRP VCE-003.2
Therapeutic area: Central Nervous System
Vivacell Biotechnology Espa VCE-004.8 Biodrugs/ Drugs Autoimmune & Inflammation
Central Nervous System
Multiple Sclerosis 1NRP VCE-004.8
Therapeutic area: Autoimmune & Inflammation
Central Nervous System
VIVEBIOTECH GMP-grade viral vectors Gene / Cell Therapy Genetic Diseases and Dysmorphic syndromes Development of gene therapy products in strict compliance with requirements established under current legislation and in accordance with best practice guidelines in a cleanroom for the production of medicines for Stage I/II clinical trials. 2RP GMP-grade viral vectors
Therapeutic area: Genetic Diseases and Dysmorphic syndromes
Vivia Biotech Vivia 011 Biodrugs/ Drugs Metabolic / Endocrinology Obesity, Diabetes 1NRP Vivia 011
Therapeutic area: Metabolic / Endocrinology
Vivia Biotech Vivia 009 Biodrugs/ Drugs Blood and Lymphatic systems
Central Nervous System
Non Hodgkin Lymphoma, CNS 2RP Europe Vivia 009
Therapeutic area: Blood and Lymphatic systems
Central Nervous System
Vytrus Biotech PhyPsor Biodrugs/ Drugs Autoimmune & Inflammation
Dermatology
Psoriasis 1NRP PhyPsor
Therapeutic area: Autoimmune & Inflammation
Dermatology